Pfizer Inc (PFE)

47.24
+0.40(+0.85%)
  • Volume:
    4,031
  • Bid/Ask:
    47.24/47.36
  • Day's Range:
    46.72 - 47.40

PFE Overview

Prev. Close
46.84
Day's Range
46.72-47.4
Revenue
99.88B
Open
46.86
52 wk Range
39.2-54.5
EPS
5.31
Volume
4,031
Market Cap
265.55B
Dividend (Yield)
1.60
(3.26%)
Average Vol. (3m)
2,690
P/E Ratio
9.36
Beta
0.642
1-Year Change
-1.24%
Shares Outstanding
5,613,314,537
Next Earnings Date
Jan 31, 2023
What is your sentiment on Pfizer?
or
Market is currently closed. Voting is open during market hours.

Pfizer Inc News

Pfizer Inc Analysis

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
79000
  • Type:Equity
  • Market:Germany
  • ISIN:US7170811035
  • WKN:852009

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Analyst Price Target

Average54.90 (+11.56% Upside)
High75
Low44
Price49.21
No. of Analysts20
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • I hope this crash and everyone invested in this diabolic company get ruined for life. All the money should go to victims of the vaxx
    1
    • An uptrend of Pfizer is a trap, and when many buyers step in, the gates will close and George Soros will hunt them down.
      0
      • Ray,, its been a while, you changed your name but other than that everything looks about the same
        0
        • Pfizer is every buyer's nightmare.
          1
          • Pfizer was born to sell short. Making money is 99.99999%.
            6
            • good vaccine!
              3
              • 3 old guys i know take this 3x and become vegetable. bad stuff.
                21
                • lie much?
                  0
                • You referring to B!den, $anders, and Fedderman? I don't think you should be making fun of them. I wouldn't do that.
                  0
              • What a dead cat bounce! Pfizer actually earns nothing, but keeps losing profits.
                11
                • What do you mean?
                  0
              • I'm glad I've been shorting Pfizer...the best way I can make a living...
                14
                • once the fines come and people go to jail you will really be making $
                  0
              • Here comes the Titanic...and Pfizer is on board. Time to sink.
                11